SCD and cancer: As a result, they constitute an attractive target for therapeutic intervention; however, inhibitors targeting these metabolic enzymes have only shown modest effects.55,56 This suggests that cancer cells may rely on alternative desaturation pathways to generate functionally useful lipid species, thus relieving their dependence on canonical SCD-mediated desaturation.